CRI-ENCI Ninth International Cancer
Immunotherapy Conference

TRANSLATING
SCIENCE INTO
SURVIVAL

Sept. 10-12, 2025 | Utrecht, The Netherlands

About the Meeting

The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are proud to present the Ninth International Cancer lmmunotherapy Conference CICON25, taking place September 10-12, 2025, in Utrecht, The Netherlands.

The CICON meeting series was launched in 2015 as a transnational forum for basic and translational research in cancer immunology and immunotherapy.

Presented by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), and alternating between the United States and Europe, CICON is organized by the leaders of this fast-moving field, gathering more than 1,000 cancer immunology and immunotherapy specialists from all over the world.

ABOUT THE PRESENTERS

The Cancer Research Institute (CRI), established in 1953, is the preeminent U.S. nonprofit organization dedicated exclusively to saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers. Guided by a world-renowned Scientific Advisory Council that includes four Nobel laureates and 34 members of the National Academy of Sciences, CRI has invested over $517 million in support of research conducted by immunologists and tumor immunologists at the world’s leading medical centers and universities and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment.

to learn more, go to

cancerresearch.org

to learn more, go to

enci.network

The European Network for Cancer Immunotherapy (ENCI) is a collaborative information and networking platform of the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), the Italian Network for Tumor Biotherapy (NIBIT) and the Spanish Group for Cancer Immuno-Biotherapy (GÉTICA). ENCI harmonizes the activities of the European cancer immunotherapy community and fosters collaboration across organizations and countries. By providing and disseminating information, organizing scientific meetings, and educating political decision makers, ENCI aims to advance the research and implementation of cancer immunotherapy in Europe.

CONFERENCE CO-CHAIRS

Özlem Türeci, Mainz, Germany
Cornelis M. Melief, Leiden, The Netherlands
Nina Bhardwaj, New York, USA
Cassian Yee, Houston, USA

CICON25 SCIENTIFIC PROGRAM COMMITTEE

Sergio Abrignani, National Institute of Molecular Genetics (INGM), Italy
Valsamo Anagnostou, Johns Hopkins Medicine, USA
Ana Arance, Hospital Clinic Barcelona, Spain
Marcel van den Brink, City of Hope, USA
Vincenzo Bronte, Istituto Oncologico Veneto IRCCS, Italy
Lorenzo Galluzzi, Fox Chase Cancer Center, USA
Manel Juan, Hospital Clinic Barcelona, Spain
Christina Leslie, Memorial Sloan Kettering Cancer Center, USA
Yifat Merbl, Weizmann Institute of Science, Israel
Catherine Sautès-Fridman, Cordeliers Research Center, France
Matthew Spitzer, UC San Francisco, USA

Save the Date in your Calendar

10 – 12 September 2025

Download the Save the Date Flyer

Follow us on LinkedIn